Using telcagepant for the acute treatment of migraine

Frederick R Taylor¹

Affiliations

Affiliation

¹ Park Nicollet Headache Clinic and Research Center, Park Nicollet Health Services, 3191 Louisiana Avenue South, E-500 Meadowbrook Building, Minneapolis, MN 55426, USA. taylo102@umn.edu

PMID: 20473786
DOI: 10.1007/s11916-010-0113-y

Comment

Using telcagepant for the acute treatment of migraine

Frederick R Taylor. Curr Pain Headache Rep. 2010 Jun.

. 2010 Jun;14(3):175-8.

doi: 10.1007/s11916-010-0113-y.

Author

Frederick R Taylor¹

Affiliation

¹ Park Nicollet Headache Clinic and Research Center, Park Nicollet Health Services, 3191 Louisiana Avenue South, E-500 Meadowbrook Building, Minneapolis, MN 55426, USA. taylo102@umn.edu

PMID: 20473786
DOI: 10.1007/s11916-010-0113-y

No abstract available

PubMed Disclaimer

Comment on

Randomized, controlled trial of telcagepant for the acute treatment of migraine.
Connor KM, Shapiro RE, Diener HC, Lucas S, Kost J, Fan X, Fei K, Assaid C, Lines C, Ho TW. Connor KM, et al. Neurology. 2009 Sep 22;73(12):970-7. doi: 10.1212/WNL.0b013e3181b87942. Neurology. 2009. PMID: 19770473 Free PMC article. Clinical Trial.

Similar articles

Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
Cui XP, Ye JX, Lin H, Mu JS, Lin M. Cui XP, et al. Pain Pract. 2015 Feb;15(2):124-31. doi: 10.1111/papr.12158. Epub 2013 Dec 30. Pain Pract. 2015. PMID: 24382126 Review.
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D. Ho TW, et al. Neurology. 2014 Sep 9;83(11):958-66. doi: 10.1212/WNL.0000000000000771. Epub 2014 Aug 8. Neurology. 2014. PMID: 25107879 Clinical Trial.
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK. Ho TW, et al. Lancet. 2008 Dec 20;372(9656):2115-23. doi: 10.1016/S0140-6736(08)61626-8. Epub 2008 Nov 25. Lancet. 2008. PMID: 19036425 Clinical Trial.
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
Connor KM, Shapiro RE, Diener HC, Lucas S, Kost J, Fan X, Fei K, Assaid C, Lines C, Ho TW. Connor KM, et al. Neurology. 2009 Sep 22;73(12):970-7. doi: 10.1212/WNL.0b013e3181b87942. Neurology. 2009. PMID: 19770473 Free PMC article. Clinical Trial.
Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.
Tfelt-Hansen P. Tfelt-Hansen P. Headache. 2011 Jan;51(1):118-23. doi: 10.1111/j.1526-4610.2010.01797.x. Epub 2010 Nov 10. Headache. 2011. PMID: 21070229 Review.

See all similar articles

References

1. Lancet. 2008 Dec 20;372(9656):2115-23 - PubMed
1. Cephalalgia. 2005 Mar;25(3):179-83 - PubMed
1. N Engl J Med. 2004 Mar 11;350(11):1104-10 - PubMed
1. Pain. 2003 Dec;106(3):461-470 - PubMed
1. Headache. 2005 Feb;45(2):156-62 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Using telcagepant for the acute treatment of migraine

Affiliation

Using telcagepant for the acute treatment of migraine

Author

Affiliation

Comment on

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources

Comment on

Similar articles

References

Publication types

Related information

LinkOut - more resources

Full Text Sources